See how your answers relate to your colleagues'.

According to the webcast

by Janet B. McGill, MD, MA, FACE and Andrew J. Ahmann, MD:
Previous studies involving patients with T1D have shown that
Increased frequency of sensor use is associated with greater reductions in HbA1c.
CGM in pump users in a crossover study had no change in HbA1c when switched from sensor off to sensor on.
Adult T1D patients who used CGM with MDI have lower percent reductions in HbA1c than those who use CGM with a pump.
All of the above

Submit is supported by independent educational grants from Insulet Corporation, Madrigal Pharmaceuticals, MannKind Corporation, Medtronic, Stanford University, and Tandem Diabetes Care, Inc.
©2024 CogniMed Inc. All rights reserved.